SCHEMBL7792895

SCHEMBL7792895

NC(=O)CC(O)C(O)C(OCc1ccccc1F)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
MAOB P27338 2/20 0.43
PARP15 Q460N3 2/20 0.43
PARP10 Q53GL7 2/20 0.43
PARP14 Q460N5 1/20 0.43
IDO1 P14902 2/20 0.41
SCN9A Q15858 1/20 0.40
SCN3A Q9NY46 5/20 0.40
SLC1A5 Q15758 1/20 0.37
DPP4 P27487 1/20 0.36
DPP7 Q9UHL4 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KCNH2 Q12809 3/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7345613 0.89 ALDH1A1 (0.54) ALDH1A1MAOBPARP15PARP10PARP14
SCHEMBL7793842 0.85 IDO1 (0.43) MAOBIDO1DPP4DPP7
SCHEMBL7792911 0.81 SLC1A3 (0.51) ALDH1A1PARP10NPC1RAB9ASMN1; SMN2
SCHEMBL7789772 0.78 MAOB (0.40) ALDH1A1MAOBPARP10IDO1DPP4
SCHEMBL7792922 0.77 MAOB (0.45) MAOBPARP10IDO1SCN9A
SCHEMBL7792899 0.75 ALDH1A1 (0.62) ALDH1A1MAOBPARP15PARP10PARP14
SCHEMBL7347112 0.73 PARP10 (0.40) ALDH1A1MAOBPARP10NPC1LMNA
SCHEMBL7794363 0.72 MAOB (0.43) ALDH1A1MAOBSLC1A5LMNAMAPT
SCHEMBL4800096 0.69 ALDH1A1 (0.46) ALDH1A1MAOBPARP15PARP10PARP14
SCHEMBL4798690 0.68 ALDH1A1 (0.49) ALDH1A1MAOBPARP15PARP10PARP14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010044547-A1 Antiviral protease inhibitors MEDIVIR AB 2001-11-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010044547-A1 Antiviral protease inhibitors PEPD, PREP, CTSL ALDH1A1 1578/4885MAOB 1597/4885PARP15 1365/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.